AKTIS ONCOLOGY INC (AKTS) Institutional Ownership and Insiders Activity
AKTIS ONCOLOGY INC (AKTS) is widely held by institutional investors, with 121 firms reporting positions valued at approximately $625.56M based on SEC Form 13F filings for the quarter ended September 30, 2026.
Mpm Bioimpact Llc is the largest disclosed holder, reporting approximately $94.15M in AKTS holdings in its latest filing.
Recent insider activity includes 6 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
121
Total Reported Value
$625.56M
Largest Holder
Mpm Bioimpact Llc
Largest Position
$94.15M
Insider Transactions (90d)
6
Latest Filing Quarter
Q3 2026
New Institutional Positions
53
Funds Exiting Positions
9
Top Institutional Owners
View allInvestorReported Balance
- Mpm Bioimpact Llc$94.15M
- Ecor1 Capital, Llc$93.93M
- Blue Owl Capital Holdings Lp$65.10M
- Blackrock, Inc.$54.14M
- Rtw Investments, Lp$31.00M
Related AKTS Institutional Insights:
- AKTS 13F Institutional Holders
- AKTS Superinvestors
- AKTS Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AKTS Insider Trading & SEC Form 4 Activity
- AKTS Articles
- Top Institutional Investor Stock Rankings